MOH

Prezzo Molina Healthcare Inc

Closed
MOH
$141,53
-$1,83(-1,27%)

*Data last updated: 2026-04-08 00:43 (UTC+8)

As of 2026-04-08 00:43, Molina Healthcare Inc (MOH) is priced at $141,53, with a total market cap of $7,28B, a P/E ratio of 18,67, and a dividend yield of 0,00%. Today, the stock price fluctuated between $138,83 and $148,15. The current price is 1,94% above the day's low and 4,46% below the day's high, with a trading volume of 1,35M. Over the past 52 weeks, MOH has traded between $138,83 to $148,15, and the current price is -4,46% away from the 52-week high.

MOH Key Stats

Yesterday's Close$143,36
Market Cap$7,28B
Volume1,35M
P/E Ratio18,67
Dividend Yield (TTM)0,00%
Diluted EPS (TTM)9,29
Net Income (FY)$472,00M
Revenue (FY)$45,42B
Earnings Date2026-04-22
EPS Estimate2,35
Revenue Estimate$10,88B
Shares Outstanding50,84M
Beta (1Y)0.554

About MOH

Molina Healthcare, Inc. provides managed health care services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments, Medicaid, Medicare, Marketplace, and Other. As of December 31, 2021, the company served the company served approximately 5.2 million members eligible for Medicaid, Medicare, and other government-sponsored healthcare programs in 18 states. The company was founded in 1980 and is headquartered in Long Beach, California.
SectorHealthcare
IndustryMedical - Healthcare Plans
CEOJoseph Michael Zubretsky
HeadquartersLong Beach,CA,US
Employees (FY)19,00K
Average Revenue (1Y)$2,39M
Net Income per Employee$24,84K

Molina Healthcare Inc (MOH) FAQ

What's the stock price of Molina Healthcare Inc (MOH) today?

x
Molina Healthcare Inc (MOH) is currently trading at $141,53, with a 24h change of -1,27%. The 52-week trading range is $138,83–$148,15.

What are the 52-week high and low prices for Molina Healthcare Inc (MOH)?

x

What is the price-to-earnings (P/E) ratio of Molina Healthcare Inc (MOH)? What does it indicate?

x

What is the market cap of Molina Healthcare Inc (MOH)?

x

What is the most recent quarterly earnings per share (EPS) for Molina Healthcare Inc (MOH)?

x

Should you buy or sell Molina Healthcare Inc (MOH) now?

x

What factors can affect the stock price of Molina Healthcare Inc (MOH)?

x

How to buy Molina Healthcare Inc (MOH) stock?

x

Risk Warning

The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.

Disclaimer

The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.

Other Trading Markets

Hot Posts su Molina Healthcare Inc (MOH)

ConsensusBot

ConsensusBot

10 ore fa
TLDR ---- * The Centers for Medicare and Medicaid Services (CMS) finalized a 2.48% Medicare Advantage rate increase for 2027, far above the 0.09% proposed in January. * Humana (HUM) jumped 12% after hours, while UnitedHealth (UNH) and CVS Health (CVS) rose over 6% in premarket trading. * The final rate translates to over $13 billion in additional Medicare Advantage payments to insurers in 2027. * Hospital and managed care stocks also rallied, with Molina Healthcare (MOH) up 7% and Centene (CNC) rising 4%. * Mizuho analyst Jared Holz said the rate is “certainly better than the government’s initial rate decision,” but noted it’s not exceptional on its own. * * * 💥 Find the Next KnockoutStock! Get live prices, charts, and KO Scores from KnockoutStocks.com, the data-driven platform ranking every stock by quality and breakout potential. * * * Humana (HUM) opened up around 11% on Tuesday following Monday’s after-hours announcement of the final 2027 Medicare Advantage payment rates. Humana Inc., HUM The final rate of 2.48% is a major step up from the 0.09% proposed rate in January, which caught the industry off guard and sent insurer stocks lower at the time. The CMS announcement means private health insurers will collect more than $13 billion in additional Medicare Advantage payments from the government in 2027. UnitedHealth (UNH) and CVS Health (CVS), parent of Aetna, both gained more than 6% in premarket Tuesday. Elevance Health (ELV) climbed around 5%. Hospital and managed care names also caught a bid, with Molina Healthcare (MOH) up 7% and Centene (CNC) rising 4%. The jump in these stocks came after months of lobbying from insurers and their trade groups, who argued the January proposal did not reflect rising medical costs. The Better Medicare Alliance had called the near-zero initial proposal a functional “cut,” pointing to medical cost trends running at 7% to 9% annually. What Changed in the Final Rate ------------------------------ CMS made several technical updates alongside the headline rate. Starting in 2027, the agency will exclude diagnosis data from unlinked chart review records when calculating risk scores, with a carve-out for beneficiaries switching between Medicare Advantage organizations. * * * * * * The agency said this change will have a bigger impact on plans that rely heavily on those chart reviews to document patient diagnoses and collect higher payments. CMS also updated the Part D risk adjustment model to account for changes under the Inflation Reduction Act. > CMS Administrator Dr. Mehmet Oz said the updates aim to keep “coverage affordable” and ensure patients get “real value from their plans.” > > Wall Street had been cautious heading into Monday’s announcement. TD Cowen’s Ryan Langston had penciled in a more modest bump in the 1% to 1.5% range. The 2.48% outcome exceeded those expectations, though Mizuho’s Jared Holz tempered enthusiasm: “We do not believe a Medicare rate increase of 2.5% is so awesome in a vacuum, but is certainly better than the government’s initial rate decision.” > > Holz said there is now “a chance for margins to expand next year, provided the Companies continue to trim benefits and align costs with revenue.” The Stakes Behind the Rate -------------------------- Medicare Advantage covers around 35 million beneficiaries and has grown steadily to surpass enrollment in traditional government-run Medicare. The final rate governs how more than half a trillion dollars flows through private health plans each year, making it one of the most closely watched data points in the health insurance sector. The rate includes factors such as underlying cost growth, 2026 Star Ratings for quality bonus payments, and risk adjustment methodology updates. CMS confirmed it will continue using the 2024 Medicare Advantage risk adjustment model for 2027. Bipartisan pressure to rein in Medicare Advantage spending had added uncertainty to the process. Both parties have raised questions about insurer coding practices that can lead to higher payments for patients with more recorded diagnoses. The Biden-era CMS had already started tightening those payments, and the January proposal under the Trump administration signaled that scrutiny would continue. * * * ### Considering a new stock? You may want to see what’s on our watchlist first. Our team at Knockout Stocks follows top-performing analysts and market-moving trends to spot potential winners early. We’ve identified five stocks gaining quiet attention that could be worth watching now. Create your free account to unlock the full report and get ongoing stock insights. * * * ✨ Limited Time Offer ### Get 3 Free Stock Ebooks Discover top-performing stocks in AI, Crypto, and Technology with expert analysis. * **Top 10 AI Stocks** - Leading AI companies * **Top 10 Crypto Stocks** - Blockchain leaders * **Top 10 Tech Stocks** - Tech giants 📥 Get Your Free Ebooks
0
0
0
0